These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7247383)

  • 1. Single-dose pharmacokinetics of acyclovir.
    Spector SA; Connor JD; Hintz M; Quinn RP; Blum MR; Keeney RE
    Antimicrob Agents Chemother; 1981 Apr; 19(4):608-12. PubMed ID: 7247383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans.
    Laskin OL; Longstreth JA; Saral R; de Miranda P; Keeney R; Lietman PS
    Antimicrob Agents Chemother; 1982 Mar; 21(3):393-8. PubMed ID: 7103443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.
    Whitley RJ; Blum MR; Barton N; de Miranda P
    Am J Med; 1982 Jul; 73(1A):165-71. PubMed ID: 7102700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal acyclovir pharmacokinetics in patients with herpes virus infections.
    Hintz M; Connor JD; Spector SA; Blum MR; Keeney RE; Yeager AS
    Am J Med; 1982 Jul; 73(1A):210-4. PubMed ID: 6285713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion.
    Spector SA; Hintz M; Wyborny C; Connor JD; Keeney RE; Liao S
    Am J Med; 1982 Jul; 73(1A):275-80. PubMed ID: 6285719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection.
    Brigden D; Bye A; Fowle AS; Rogers H
    J Antimicrob Chemother; 1981 Apr; 7(4):399-404. PubMed ID: 7251524
    [No Abstract]   [Full Text] [Related]  

  • 7. Acyclovir kinetics after intravenous infusion.
    de Miranda P; Whitley RJ; Blum MR; Keeney RE; Barton N; Cocchetto DM; Good S; Hemstreet GP; Kirk LE; Page DA; Elion GB
    Clin Pharmacol Ther; 1979 Dec; 26(6):718-28. PubMed ID: 227639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of intravenous radioactive acyclovir.
    de Miranda P; Good SS; Laskin OL; Krasny HC; Connor JD; Lietman PS
    Clin Pharmacol Ther; 1981 Nov; 30(5):662-72. PubMed ID: 7297024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in the disposition of acyclovir.
    de Miranda P; Krasny HC; Page DA; Elion GB
    Am J Med; 1982 Jul; 73(1A):31-5. PubMed ID: 7102710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyclovir clinical pharmacology. An overview.
    Lietman PS
    Am J Med; 1982 Jul; 73(1A):193-6. PubMed ID: 7048912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir kinetics in end-stage renal disease.
    Laskin OL; Longstreth JA; Whelton A; Rocco L; Lietman PS; Krasny HC; Keeney RE
    Clin Pharmacol Ther; 1982 May; 31(5):594-601. PubMed ID: 7075109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of acyclovir pharmacokinetic disposition in adults and children.
    Blum MR; Liao SH; de Miranda P
    Am J Med; 1982 Jul; 73(1A):186-92. PubMed ID: 7048911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis.
    Van Dyke RB; Connor JD; Wyborny C; Hintz M; Keeney RE
    Am J Med; 1982 Jul; 73(1A):172-5. PubMed ID: 7102701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function after acyclovir intravenous injection.
    Brigden D; Rosling AE; Woods NC
    Am J Med; 1982 Jul; 73(1A):182-5. PubMed ID: 6285711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic fate of radioactive acyclovir in humans.
    de Miranda P; Good SS; Krasny HC; Connor JD; Laskin OL; Lietman PS
    Am J Med; 1982 Jul; 73(1A):215-20. PubMed ID: 7102704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey.
    Good SS; de Miranda P
    Am J Med; 1982 Jul; 73(1A):91-5. PubMed ID: 7102713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of acyclovir in different species.
    de Miranda P; Krasny HC; Page DA; Elion GB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):309-15. PubMed ID: 7288622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of oral acyclovir in patients on continuous ambulatory peritoneal dialysis.
    Stathoulopoulou F; Almond MK; Dhillon S; Raftery MJ
    Nephron; 1996; 74(2):337-41. PubMed ID: 8893152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans.
    Soul-Lawton J; Seaber E; On N; Wootton R; Rolan P; Posner J
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2759-64. PubMed ID: 8593015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.
    Laskin OL; de Miranda P; King DH; Page DA; Longstreth JA; Rocco L; Lietman PS
    Antimicrob Agents Chemother; 1982 May; 21(5):804-7. PubMed ID: 7103460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.